Which hematopoietic stem cell transplantation type is safe for patients with hepatitis B virus carriers.

被引:0
|
作者
Üstün, C
Idilman, R
Özcan, M
Akan, H
Karayalcin, S
Gürman, G
Ilhan, O
Beksac, M
Uysal, A
Konuk, N
Demirer, T
Koc, H
机构
[1] Ankara Univ, Dept Gastroenterol, TR-06100 Ankara, Turkey
[2] Ankara Univ, Dept Hematol, TR-06100 Ankara, Turkey
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
2221
引用
收藏
页码:718A / 718A
页数:1
相关论文
共 50 条
  • [21] Hepatitis B Reactivation in Occult Viral Carriers Undergoing Hematopoietic Stem Cell Transplantation: A Prospective Study
    Seto, Wai-Kay
    Chan, Thomas Sau-Yan
    Hwang, Yu-Yan
    Wong, Danny Ka-Ho
    Fung, James
    Liu, Kevin Sze-Hang
    Gill, Harinder
    Lam, Yuk-Fai
    Lau, Eric H. Y.
    Cheung, Ka-Shing
    Lie, Albert K. W.
    Lai, Ching-Lung
    Kwong, Yok-Lam
    Yuen, Man-Fung
    HEPATOLOGY, 2017, 65 (05) : 1451 - 1461
  • [22] Efficacy and tolerability of Entecavir for hepatitis B virus infection after hematopoietic stem cell transplantation
    Aoki, Jun
    Kimura, Kiminori
    Kakihana, Kazuhiko
    Ohashi, Kazuteru
    Sakamaki, Hisashi
    SPRINGERPLUS, 2014, 3
  • [23] Screening of hepatitis B virus before hematopoietic cell transplantation
    Nakaya, A.
    Fujita, S.
    Satake, A.
    Nakanishi, T.
    Azuma, Y.
    Tsubokura, Y.
    Hotta, M.
    Yoshimura, H.
    Ishii, K.
    Ito, T.
    Nomura, S.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S581 - S581
  • [24] Retrospective Study on the Impact of Hepatitis B and Hepatitis C Virus Infection on Hematopoietic Stem Cell Transplantation in Japan
    Motohiro Hamaguchi
    Hironori Yamad
    Hisashi Gondo
    Yoshinobu Takemoto
    Yasuo Morishima
    Yoshihisa Kodera
    International Journal of Hematology, 2002, 75 : 324 - 331
  • [25] Retrospective study on the impact of hepatitis B and hepatitis C virus infection on hematopoietic stem cell transplantation in Japan
    Hamaguchi, M
    Yamada, H
    Gondo, H
    Takemoto, Y
    Morishima, Y
    Kodera, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (03) : 324 - 331
  • [26] Reduced therapeutic effect of antiviral drugs in patients with hepatitis B virus reactivation after hematopoietic stem cell transplantation
    Kimura, Masamichi
    Nishikawa, Koji
    Sakamaki, Hisashi
    Mizokami, Masashi
    Kimura, Kiminori
    HEPATOLOGY RESEARCH, 2018, 48 (06) : 469 - 478
  • [27] Hepatitis B Virus Reactivation with Discontinuation of Nucleoside Analogue in Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation
    Tsuruoka, Mio
    Inoue, Jun
    Onishi, Yasushi
    Ninomiya, Masashi
    Kakazu, Eiji
    Iwata, Tomoaki
    Sano, Akitoshi
    Sato, Kosuke
    Harigae, Hideo
    Masamune, Atsushi
    CASE REPORTS IN GASTROENTEROLOGY, 2021, 15 (01) : 178 - 187
  • [28] Genetic variability of hepatitis B virus and vaccinotherapy in chronic HBV carriers.
    Soussan, P
    Pol, S
    Petit, MA
    Berthelot, P
    Brechot, C
    Kremsdorf, D
    HEPATOLOGY, 1996, 24 (04) : 1823 - 1823
  • [29] Changes of Hepatitis B Virus Serologic Status after Allogeneic Hematopoietic Stem Cell Transplantation and Impact of Donor Immunity on Hepatitis B Virus
    Park, Silvia
    Kim, Kihyun
    Kim, Dong Hwan
    Fang, Jun Ho
    Kim, Seok Jin
    Kim, Won Seog
    Jung, Chul Won
    Koh, Kwang Cheol
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (11) : 1630 - 1637
  • [30] Hepatitis B and hepatitis C virus infections in stem cell transplantation
    Locasciulli, A
    Alberti, A
    LEUKEMIA & LYMPHOMA, 1999, 35 (3-4) : 255 - 260